The founder and chief scientist of Clarity Pharma Research LLC, r. Gallagher, is a well-known international researcher and conference presenter in the fields of medicine and healthcare. He is also the editor of Current Trends in Clinical and Medical Sciences, a subject matter expert for the journal chemotherapy, and a former director of a multi-university research consortium (University of Virginia School of Medicine). In addition to winning first place for a paper on upcoming challenges at the Second International Conference on Marketing and Development in Budapest, he has written more than 140 scientific publications. His real-world research presentation on the effects of PARP inhibitors at the 2018 European Society for Medical Oncology Congress (Munich) was featured in an interview by OncLive, which was chosen for distribution to oncologists all over the world and published in Future Oncology (Dec. 2019). At PCS 4th Global Obstetrics, he served as co-chair of the sessions on gynaecological oncology.
Former decathlete, clinical psychologist, expert in epidemiology, and creator of a remote-control guidance system for blind athletes.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
